Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Stock data | 2023 | Change |
---|---|---|
Price | $27.73 | N/A |
Market Cap | $234.70M | N/A |
Shares Outstanding | 8.46M | -0.09% |
Employees | 170.00 | N/A |
Shareholder Equity | 37.67M | 10.22% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 77.03 | N/A |
P/S Ratio | 4.88 | N/A |
P/B Ratio | 6.23 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0841 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $48.07M | N/A |
Earnings | $3.17M | N/A |
EPS | 0.36 | N/A |
Earnings Yield | 0.013 | N/A |
Gross Margin | 0.7598 | N/A |
Operating Margin | 0.0834 | N/A |
Net income margin | 0.0659 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $45.81M | N/A |
Cash on Hand | $7.37M | N/A |
Debt to Equity | 0.2161 | 2.68% |
Current Ratio | $4.69 | -2.86% |